While lower price playing cards can help alleviate the load of large drug costs from the temporary, they do not deal with the systemic issues driving up prescription prices within the U.S. Broader policy improvements could deal with the foundation brings about of soaring drug costs, which include insufficient transparency in pricing and the purpose